A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer
Clinical trial NCT01196052 · COMPLETED
Trial details
- NCT number
- NCT01196052
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.